Advertisement
New Zealand markets closed
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NZD/USD

    0.5896
    -0.0010 (-0.17%)
     
  • NZD/EUR

    0.5534
    -0.0011 (-0.20%)
     
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • OIL

    83.75
    +1.02 (+1.23%)
     
  • GOLD

    2,401.20
    +3.20 (+0.13%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,840.02
    -37.03 (-0.47%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,651.81
    -185.59 (-1.04%)
     
  • Hang Seng

    16,245.37
    -140.50 (-0.86%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • NZD/JPY

    91.0170
    -0.2370 (-0.26%)
     

Will Investors Win With Johnson & Johnson's Planned Spinoff? Here's What History Shows

Will Investors Win With Johnson & Johnson's Planned Spinoff? Here's What History Shows

Johnson & Johnson (NYSE: JNJ) announced last week that it plans to spin off its consumer healthcare business into a separate publicly traded entity. J&J said that this move will unlock shareholder value and accelerate growth. Pfizer (NYSE: PFE) and GlaxoSmithKline established a joint venture for their consumer health units.